These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24548894)

  • 1. Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.
    Zhang X; Fryknäs M; Hernlund E; Fayad W; De Milito A; Olofsson MH; Gogvadze V; Dang L; Påhlman S; Schughart LA; Rickardson L; D'Arcy P; Gullbo J; Nygren P; Larsson R; Linder S
    Nat Commun; 2014; 5():3295. PubMed ID: 24548894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
    Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
    Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron chelators target both proliferating and quiescent cancer cells.
    Fryknäs M; Zhang X; Bremberg U; Senkowski W; Olofsson MH; Brandt P; Persson I; D'Arcy P; Gullbo J; Nygren P; Schughart LK; Linder S; Larsson R
    Sci Rep; 2016 Dec; 6():38343. PubMed ID: 27924826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.
    Vitiello GA; Medina BD; Zeng S; Bowler TG; Zhang JQ; Loo JK; Param NJ; Liu M; Moral AJ; Zhao JN; Rossi F; Antonescu CR; Balachandran VP; Cross JR; DeMatteo RP
    Clin Cancer Res; 2018 Feb; 24(4):972-984. PubMed ID: 29246941
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer.
    Senkowski W; Zhang X; Olofsson MH; Isacson R; Höglund U; Gustafsson M; Nygren P; Linder S; Larsson R; Fryknäs M
    Mol Cancer Ther; 2015 Jun; 14(6):1504-16. PubMed ID: 25911689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer strategy targeting the energy metabolism of tumor cells surviving a low-nutrient acidic microenvironment.
    Maeda Y; Kikuchi R; Kawagoe J; Tsuji T; Koyama N; Yamaguchi K; Nakamura H; Aoshiba K
    Mol Metab; 2020 Dec; 42():101093. PubMed ID: 33007425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
    Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.
    Kanakkanthara A; Kurmi K; Ekstrom TL; Hou X; Purfeerst ER; Heinzen EP; Correia C; Huntoon CJ; O'Brien D; Wahner Hendrickson AE; Dowdy SC; Li H; Oberg AL; Hitosugi T; Kaufmann SH; Weroha SJ; Karnitz LM
    Cancer Res; 2019 Dec; 79(23):5920-5929. PubMed ID: 31619387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system--a unique mitochondrial energy metabolism in tumour microenvironments.
    Tomitsuka E; Kita K; Esumi H
    J Biochem; 2012 Aug; 152(2):171-83. PubMed ID: 22528668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
    Ju R; Fei K; Li S; Chen C; Zhu L; Li J; Zhang D; Guo L; Ye C
    J Pharmacol Exp Ther; 2018 Oct; 367(1):20-27. PubMed ID: 30002095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
    Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
    J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
    Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
    Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Huang Y; Zhou J; Luo S; Wang Y; He J; Luo P; Chen Z; Liu T; Tan X; Ou J; Miao H; Liang H; Shi C
    Gut; 2018 Feb; 67(2):307-319. PubMed ID: 27849558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma.
    Maillet A; Yadav S; Loo YL; Sachaphibulkij K; Pervaiz S
    Cell Death Dis; 2013 Jun; 4(6):e653. PubMed ID: 23744353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons.
    Benavides GA; Liang Q; Dodson M; Darley-Usmar V; Zhang J
    Free Radic Biol Med; 2013 Dec; 65():1215-1228. PubMed ID: 24056030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
    Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
    Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent.
    Wang L; Zhao S; Bao G; Zhang Y; Xi S; Zhou G; Zhai X; Gong P
    Med Chem; 2016; 12(7):621-630. PubMed ID: 26732116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.